The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Drug Therapy
PreviousPrevious
Volume 343:710-722 September 7, 2000 Number 10
NextNext

Treatment of Acute Ischemic Stroke
Thomas Brott, M.D., and Julien Bogousslavsky, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Ischemic stroke exacts a heavy toll in death and disability worldwide. In the United States, where it is the third leading cause of death and the leading cause of serious long-term disability, approximately 750,000 strokes occur annually, with an annual mortality rate exceeding 150,000.1,2,3,4

In June 1996, the Food and Drug Administration (FDA) approved tissue plasminogen activator (t-PA) as a safe and effective treatment for stroke if it is given within three hours after the onset of symptoms of stroke.5 Subsequently, results of large clinical trials testing the efficacy of antiplatelet, antithrombotic, and neuroprotective treatments appeared. More recently, intraarterial thrombolytic . . . [Full Text of this Article]

Pathophysiology and Targets for Intervention

Early Evaluation and Supportive Treatment

Intravenous Thrombolytic Therapy

Intraarterial Thrombolytic Therapy

Antithrombotic and Antiplatelet Drugs

Heparin

Aspirin

Ancrod

Neuroprotection

Treatment in the Hospital

Integrated Stroke-Intervention Teams and Stroke Units

Rehabilitation

Conclusions


Source Information

From the Department of Neurology, Mayo Clinic, Jacksonville, Fla. (T.B.); and the Department of Neurology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (J.B.).

Address reprint requests to Dr. Brott at the Department of Neurology, Mayo Clinic, 4500 San Pablo Rd., Jacksonville, FL 32224, or at brott.thomas@mayo.edu.

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.